Related references
Note: Only part of the references are listed.Impact of the National Centralized Drug Procurement Policy (4+7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series
Tianwei Lan et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2022)
Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design
Yu-Fei Hua et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study
Wen Hu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Purchasing medicines for the public sector: Evaluation of the performance of centralised procurement in Portugal
Sabine Vogler et al.
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2022)
A systematic review of pooled procurement of medicines and vaccines: identifying elements of success
Koray Parmaksiz et al.
GLOBALIZATION AND HEALTH (2022)
Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
Hongfei Long et al.
FRONTIERS IN PHARMACOLOGY (2022)
The impacts of the 4+7 pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
Xiaotong Wen et al.
FRONTIERS IN PHARMACOLOGY (2022)
The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China
Yuan-jin Zhang et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Assessment of the Reliability of the Polish Language Version of the FATCOD-B Scale Among Nursing Students
Anna Sadowska et al.
JOURNAL OF CANCER EDUCATION (2021)
Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
Ni Wang et al.
BMC PUBLIC HEALTH (2021)
Knowledge, Attitudes, and Practices of Antimicrobial Uses and Resistance Among Public University Students in Bangladesh
Mahfuza Marzan et al.
INFECTION AND DRUG RESISTANCE (2021)
Knowledge, perceptions and practices of pharmacists regarding generic substitution in China: a cross-sectional study
Jinghan Qu et al.
BMJ OPEN (2021)
Correlation of Knowledge, Attitude, and Practice Toward Probiotics for the Digestive System Among Health Science Students
Pinka Alia Rahmah et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2021)
The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis
Ying Yang et al.
BMC HEALTH SERVICES RESEARCH (2021)
Using Social Media and Snowball Sampling as an Alternative Recruitment Strategy for Research
Kim Leighton et al.
CLINICAL SIMULATION IN NURSING (2021)
Pooled procurement of drugs in low and middle income countries
Pierre Dubois et al.
EUROPEAN ECONOMIC REVIEW (2021)
Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda
Patrick Gad Iradukunda et al.
JOURNAL OF COMMUNITY HEALTH (2021)
Impact of 'Chief-Pharmacist System' on drug expenditures and rational drug use
Zhuo Ma et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2020)
Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study
Kidu Gidey et al.
BMJ OPEN (2020)
Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China
M. Zhang et al.
JOURNAL OF HOSPITAL INFECTION (2020)
The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
Lei Chen et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Knowledge, Attitude and Practice toward COVID-19 among Egyptians
Zeinab A. Kasemy et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2020)
Reasons for the Underutilization of Generic Drugs by US Ophthalmologists: A Survey
Jamie Dietze et al.
OPHTHALMOLOGY AND THERAPY (2020)
Drug Information Association Pharmacovigilance and Risk Management Strategies 2017: Overview of the Generic Drug Program and Surveillance
Howard D. Chazin et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2019)
Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study
Yunzhen He et al.
PLOS ONE (2018)
The Use of Cronbach's Alpha When Developing and Reporting Research Instruments in Science Education
Keith S. Taber
RESEARCH IN SCIENCE EDUCATION (2018)
Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs
Richard A. Hansen et al.
PHARMACOTHERAPY (2017)
Knowledge, attitudes and practices of community pharmacists on generic medicines in Palestine: a cross-sectional study
Naser Y. Shraim et al.
BMC HEALTH SERVICES RESEARCH (2017)
Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries
Gabriel Seidman et al.
BMJ GLOBAL HEALTH (2017)
Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
Niteesh K. Choudhry et al.
ANNALS OF INTERNAL MEDICINE (2016)
Prevalence and Predictors of Generic Drug Skepticism Among Physicians: Results of a National Survey
Aaron S. Kesselheim et al.
JAMA INTERNAL MEDICINE (2016)
Physician and pharmacist perceptions of generic medicines: What they think and how they differ
Suzanne Dunne et al.
HEALTH POLICY (2014)
Physician Perceptions About Generic Drugs
William H. Shrank et al.
ANNALS OF PHARMACOTHERAPY (2011)